eTMF RFI & RFP Template: A Practical Guide to eTMF Vendor Selection

Selecting an electronic Trial Master File (eTMF) system is a defining decision for clinical operations and quality teams. Beyond functionality, the chosen platform must support inspection readiness, enable oversight across stakeholders, and scale with the complexity of modern clinical trials.

For many organizations, the challenge is not a lack of vendor options, but a lack of structure in how those options are evaluated. Without a consistent framework, decisions can become influenced by demonstrations, feature lists, or short-term project needs—rather than long-term compliance and operational fit.

A well-designed Request for Information (RFI) or Request for Proposal (RFP) introduces that structure. It enables sponsors and CROs to evaluate eTMF vendors in a way that is consistent, defensible, and aligned with regulatory expectations.

At PHARMASEAL, we work with organizations navigating this process, helping teams define evaluation approaches that reflect both inspection realities and day-to-day trial execution.

Why Structure Matters in eTMF Vendor Selection

eTMF systems sit at the centre of clinical trial documentation. As such, the implications of vendor selection extend beyond implementation into inspection readiness, ongoing oversight, and long-term data integrity.

In practice, many organizations begin their evaluation process informally—reviewing vendor materials, attending demonstrations, and gathering internal feedback. While these steps are important, they rarely provide a complete or objective basis for decision-making. Critical considerations such as validation approach, audit trail integrity, or document lifecycle control may not be consistently assessed.

A structured RFI or RFP addresses this gap. It establishes a common framework for comparison, ensures that all vendors are evaluated against the same criteria, and creates a documented record of due diligence. This is particularly important in regulated environments, where decisions may later need to be justified during an inspection.

Understanding the Role of RFI and RFP in eTMF Selection

Although closely related, RFIs and RFPs serve different roles within the evaluation process.

An eTMF RFI is typically used at an early stage to build understanding and narrow the field. It allows organizations to assess whether vendors meet baseline expectations around compliance, security, and core functionality. In many cases, a lighter version—often referred to as an “RFI Lite”—is sufficient to identify a shortlist of viable providers.

An eTMF RFP follows once that shortlist has been established. At this stage, the focus shifts to deeper evaluation. Organizations seek to understand how systems will be implemented, how responsibilities will be shared, and how the platform will perform within their specific operating model. Commercial considerations are also introduced, alongside more detailed technical and functional assessment.

Together, the RFI and RFP provide a structured pathway from initial exploration to final selection. If you are preparing an RFI for eTMF vendor selection, this staged approach helps keep early shortlisting distinct from detailed technical, operational and commercial evaluation.

Regulatory Expectations and Vendor Due Diligence

Regulators are increasingly focused on how organizations manage their Trial Master File, including the systems used to maintain it. This extends beyond system functionality to include governance, validation, and vendor oversight.

During inspections, it is not uncommon for assessors to explore how key systems were selected. They may look for evidence that compliance requirements were considered, that risks were assessed, and that decisions were made in a controlled and transparent manner.

A documented RFI or RFP can support this narrative. It demonstrates that vendor selection was not ad hoc, but based on defined criteria aligned with regulatory expectations. In this sense, the RFI/RFP process contributes not only to better decision-making, but also to inspection readiness.

Building a Practical eTMF RFI or RFP

An effective eTMF RFI or RFP does not need to be overly complex, but it does need to be comprehensive in the right areas. The most successful frameworks balance regulatory requirements with operational realities.

At a minimum, the evaluation should establish a clear understanding of the vendor’s experience in regulated environments and their ability to support inspection-ready processes. It should explore how the platform aligns with accepted TMF structures, and how it manages document lifecycle, metadata, and auditability.

Equally important is the vendor’s approach to validation and compliance. This includes how the system is qualified, how changes are controlled, and how ongoing compliance is maintained over time. Security and data privacy considerations must also be addressed in a way that reflects current expectations around data protection and system resilience.

Beyond compliance, the evaluation should consider how the system will function in practice. This includes how documents are ingested and reviewed, how completeness is tracked, and how stakeholders interact within the system. Implementation and migration approaches are particularly important, as these are often the areas where projects encounter delays or unexpected complexity.

Finally, for RFPs, commercial and contractual considerations provide the necessary context for decision-making. Pricing models, scalability, and data ownership all play a role in determining long-term fit. A practical RFI template for eTMF evaluation should make these criteria easy to compare while retaining space for organization-specific requirements.

Aligning the Evaluation to Your Operating Model—eTMF RFI for CROs vs eTMF RFI for Biotech

While the core structure of an RFI or RFP is broadly consistent, priorities will vary depending on the organization.

Biotech sponsors, particularly those building clinical capabilities for the first time, often prioritise simplicity, speed of deployment, and clear oversight of outsourced activities. For these organizations, the eTMF must support inspection readiness from the outset without requiring extensive internal resources.

CROs, by contrast, operate in multi-sponsor environments where consistency and scalability are critical. Their evaluation will place greater emphasis on standardisation, operational efficiency, and the ability to accommodate varying sponsor requirements without compromising quality.

Recognising these differences ensures that the RFI or RFP is not only comprehensive, but also relevant to how the system will actually be used.

Supporting a Defensible and Effective Decision

Ultimately, the purpose of an eTMF RFI or RFP is not simply to compare vendors, but to support a decision that can be justified over time. This requires input from across clinical operations, quality, and IT, as well as a clear understanding of both current and future needs.

A structured evaluation process enables organizations to move beyond subjective impressions and towards a more objective, evidence-based decision. It also provides a record that can be referenced in the future, whether during internal review or regulatory inspection.

To support this process, PHARMASEAL has developed a practical, regulator-aligned eTMF RFI/RFP template designed for sponsors and CROs.

The template provides a structured framework for vendor evaluation, including guidance on key areas such as compliance, validation, operational fit, and implementation. It is intended to be adapted to your organisation’s specific requirements while maintaining alignment with regulatory expectations.

Download the RFI/RFP Template for eTMF to support a consistent, defensible approach to eTMF vendor selection.